Georgia Carroll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Georgia Carroll has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Stephen Ridley Smith
School of Medicine and Public Health, University of Newcastle, 150 University Drive, Callaghan, New South Wales, 2308, Australia, 61 2 4042 0964
4 shared publications - Alison Rutledge
Department of Surgery, John Hunter Hospital, Newcastle, New South Wales, Australia
2 shared publications - Jonathan Gani
John Hunter Hospital, Newcastle, New South Wales, Australia
2 shared publications Rodney J. Scott
Hunter Medical Research Institute New Lambton Heights New South Wales Australia
2 shared publicationsRosemary Carroll
Division of Surgery John Hunter Hospital New Lambton Heights New South Wales Australia
2 shared publicationsAndrea Mathe
School of Biomedical Sciences & Pharmacy, Faculty of Health & Medicine, University of Newcastle, Newcastle, NSW, Australia
1 shared publication
Latest Publications
- Open Access
- 9 June 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (7-8) , 2010-2017
A Novel Blood‐Based Screening Test for Colorectal Cancer Using Raman Spectroscopy
Background: Label‐free vibrational spectroscopic techniques (Raman spectroscopy) combined with machine learning (ML) methodologies have huge potential for the development of screening and diagnostic tests in oncology. Traditionally, screening for colorectal cancer (CRC) has relied on immunochemical faecal occult blood (iFOBT) testing; however, this has shown to have low compliance in the Australian setting. The aim of this study was to assess the efficacy of Raman spectroscopy for the detection of CRC and potential screening for CRC. Methods: Plasma samples were analysed from a total of 370 participants; 117 CRC patients and 253 iFOBT positive control participants. 8 of the CRC patients were from the iFOBT cohort. The control cohort had either advanced adenomas ( n = 81), non‐advanced adenomas ( n = 76), colitis ( n = 2) or no evidence of disease ( n = 94). The Raman spectra of these plasma samples were analysed using ML algorithms in separate training ( n = 222) and validation ( n = 148) cohorts. Results: A sensitivity of 84% and specificity of 93% was achieved for the detection of CRC in the validation cohort. When analysed in subcategories, 95% of people with CRC would receive a colonoscopy and 42% of FIT positive people could potentially be spared a colonoscopy. Conclusion: This exploratory study demonstrated a high level of accuracy for the detection of CRC using a Raman spectroscopy‐based ML model and has the potential to be used for CRC screening.
- 9 June 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (7-8) , 2010-2017
Open AccessA Novel Blood‐Based Screening Test for Colorectal Cancer Using Raman Spectroscopy
Background: Label‐free vibrational spectroscopic techniques (Raman spectroscopy) combined with machine learning (ML) methodologies have huge potential for the development of screening and diagnostic tests in oncology. Traditionally, screening for colorectal cancer (CRC) has relied on immunochemical faecal occult blood (iFOBT) testing; however, this has shown to have low compliance in the Australian setting. The aim of this study was to assess the efficacy of Raman spectroscopy for the detection of CRC and potential screening for CRC. Methods: Plasma samples were analysed from a total of 370 participants; 117 CRC patients and 253 iFOBT positive control participants. 8 of the CRC patients were from the iFOBT cohort. The control cohort had either advanced adenomas ( n = 81), non‐advanced adenomas ( n = 76), colitis ( n = 2) or no evidence of disease ( n = 94). The Raman spectra of these plasma samples were analysed using ML algorithms in separate training ( n = 222) and validation ( n = 148) cohorts. Results: A sensitivity of 84% and specificity of 93% was achieved for the detection of CRC in the validation cohort. When analysed in subcategories, 95% of people with CRC would receive a colonoscopy and 42% of FIT positive people could potentially be spared a colonoscopy. Conclusion: This exploratory study demonstrated a high level of accuracy for the detection of CRC using a Raman spectroscopy‐based ML model and has the potential to be used for CRC screening.
- 12 December 2025
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (3) , 676-677
The Challenge of Recurrent Presumed Adhesional Small Bowel Obstruction: How Magnetic Resonance Enterography Might Help
- 12 December 2025
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (3) , 676-677
The Challenge of Recurrent Presumed Adhesional Small Bowel Obstruction: How Magnetic Resonance Enterography Might Help
- Open Access
- 6 April 2023
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (10) , 2464-2472
A pilot study: intraoperative 16S rRNA sequencing versus culture in predicting colorectal incisional surgical site infection
Background: Surgical Site Infection (SSI) of the abdominal incision is a dreaded complication following colorectal surgery. Identifying the intraoperative surgical site microbes may provide clarity in the pathogenesis of SSIs. Genomic sequencing has revolutionized the ability to identify microbes from clinical samples. Utilization of 16S rRNA amplicon sequencing to characterize the intraoperative surgical site may provide the critical information required to predict and prevent infection in colorectal surgery.Methods: This is a pilot, prospective observational study of 50 patients undergoing elective colorectal resection. At completion of surgery, prior to skin closure, swabs were taken from the subcutaneous tissue of the abdominal incision to investigate the microbial profile. Dual swabs were taken to compare standard culture technique and 16S rRNA sequencing to establish if a microbial profile was associated with postoperative SSI.Results: 8/50 patients developed an SSI, which was more likely in those undergoing open surgery (5/15 33.3% versus 3/35, 8.6%; P = 0.029). 16S rRNA amplicon sequencing was more sensitive in microbial detection compared to traditional culture. Both culture and 16S rRNA demonstrated contamination of the surgical site, predominantly with anaerobes. Culture was not statistically predictive of infection. 16S rRNA amplicon sequencing was not statistically predictive of infection, however, it demonstrated patients with an SSI had an increased biodiversity (not significant) and a greater relative abundance (not significant) of pathogens such as Bacteroidacaea and Enterobacteriaceae within the intraoperative site.Conclusions: 16S rRNA amplicon sequencing has demonstrated a potential difference in the intraoperative microbial profile of those that develop an infection. These findings require validation through powered experiments to determine the overall clinical significance.
- 6 April 2023
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (10) , 2464-2472
Open AccessA pilot study: intraoperative 16S rRNA sequencing versus culture in predicting colorectal incisional surgical site infection
Background: Surgical Site Infection (SSI) of the abdominal incision is a dreaded complication following colorectal surgery. Identifying the intraoperative surgical site microbes may provide clarity in the pathogenesis of SSIs. Genomic sequencing has revolutionized the ability to identify microbes from clinical samples. Utilization of 16S rRNA amplicon sequencing to characterize the intraoperative surgical site may provide the critical information required to predict and prevent infection in colorectal surgery.Methods: This is a pilot, prospective observational study of 50 patients undergoing elective colorectal resection. At completion of surgery, prior to skin closure, swabs were taken from the subcutaneous tissue of the abdominal incision to investigate the microbial profile. Dual swabs were taken to compare standard culture technique and 16S rRNA sequencing to establish if a microbial profile was associated with postoperative SSI.Results: 8/50 patients developed an SSI, which was more likely in those undergoing open surgery (5/15 33.3% versus 3/35, 8.6%; P = 0.029). 16S rRNA amplicon sequencing was more sensitive in microbial detection compared to traditional culture. Both culture and 16S rRNA demonstrated contamination of the surgical site, predominantly with anaerobes. Culture was not statistically predictive of infection. 16S rRNA amplicon sequencing was not statistically predictive of infection, however, it demonstrated patients with an SSI had an increased biodiversity (not significant) and a greater relative abundance (not significant) of pathogens such as Bacteroidacaea and Enterobacteriaceae within the intraoperative site.Conclusions: 16S rRNA amplicon sequencing has demonstrated a potential difference in the intraoperative microbial profile of those that develop an infection. These findings require validation through powered experiments to determine the overall clinical significance.
- 28 October 2020
- Published by Wiley in Anz Journal of Surgery
- Vol. 91 (6) , 1311-1313
Lollipop in a haystack: an unusual case of foreign body caecal perforation mimicking appendicitis
- 28 October 2020
- Published by Wiley in Anz Journal of Surgery
- Vol. 91 (6) , 1311-1313
Lollipop in a haystack: an unusual case of foreign body caecal perforation mimicking appendicitis
- 1 April 2019
- Published by Elsevier in Journal of Surgical Research
- Vol. 236, 184-197
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
- 1 April 2019
- Published by Elsevier in Journal of Surgical Research
- Vol. 236, 184-197
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review
- 14 November 2018
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 114 (3) , 429-436
Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review
BACKGROUND: Subtle histopathologic features such as eosinophilia and increased mast cells have been observed in functional gastrointestinal disorders (FGIDs), including functional dyspepsia (FD) and the irritable bowel syndrome (IBS). The mechanisms that drive recruitment of these cells to the gastrointestinal tract remain unexplained, largely due to the heterogeneity in phenotypes among patients diagnosed with such conditions. We aimed to systematically review the literature and collate the evidence for immune activation in FD and IBS, and where possible, detail the nature of activation. METHODS: Seven literature databases were searched using the keywords: ‘functional gastrointestinal disorder’, FGID, ‘functional dyspepsia’, ‘non-ulcer dyspepsia’, ‘idiopathic dyspepsia’, ‘irritable bowel syndrome’, IBS and ‘immun*’. RESULTS: Fifty-one papers reporting discordant immune features met the selection criteria for this review. Changes in lymphocyte populations, including B and T lymphocyte numbers and activation status were reported in IBS and FD, in conjunction with duodenal eosinophilia in FD and increased colonic mast cells in IBS. Increases in circulating α4+β7+ gut-homing T cells appear to be linked to the pathophysiology of both FD and IBS. Studies in the area are complicated by poor phenotyping of patients into subgroups and the subtle nature of the immune activity involved in FD and IBS. CONCLUSIONS: Alterations in proportions of gut-homing T lymphocytes in both FD and IBS indicate that a loss of mucosal homeostasis may drive the symptoms of FD and IBS. There is indirect evidence that Th17 responses may play a role in FGIDs, however the evidence for a Th2 immune phenotype in FD and IBS is limited. Although immune involvement is evident, large, well-characterised patient cohorts are required to elucidate the immune mechanisms driving the development of FGIDs.
- 14 November 2018
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 114 (3) , 429-436
Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review
BACKGROUND: Subtle histopathologic features such as eosinophilia and increased mast cells have been observed in functional gastrointestinal disorders (FGIDs), including functional dyspepsia (FD) and the irritable bowel syndrome (IBS). The mechanisms that drive recruitment of these cells to the gastrointestinal tract remain unexplained, largely due to the heterogeneity in phenotypes among patients diagnosed with such conditions. We aimed to systematically review the literature and collate the evidence for immune activation in FD and IBS, and where possible, detail the nature of activation. METHODS: Seven literature databases were searched using the keywords: ‘functional gastrointestinal disorder’, FGID, ‘functional dyspepsia’, ‘non-ulcer dyspepsia’, ‘idiopathic dyspepsia’, ‘irritable bowel syndrome’, IBS and ‘immun*’. RESULTS: Fifty-one papers reporting discordant immune features met the selection criteria for this review. Changes in lymphocyte populations, including B and T lymphocyte numbers and activation status were reported in IBS and FD, in conjunction with duodenal eosinophilia in FD and increased colonic mast cells in IBS. Increases in circulating α4+β7+ gut-homing T cells appear to be linked to the pathophysiology of both FD and IBS. Studies in the area are complicated by poor phenotyping of patients into subgroups and the subtle nature of the immune activity involved in FD and IBS. CONCLUSIONS: Alterations in proportions of gut-homing T lymphocytes in both FD and IBS indicate that a loss of mucosal homeostasis may drive the symptoms of FD and IBS. There is indirect evidence that Th17 responses may play a role in FGIDs, however the evidence for a Th2 immune phenotype in FD and IBS is limited. Although immune involvement is evident, large, well-characterised patient cohorts are required to elucidate the immune mechanisms driving the development of FGIDs.
- 22 May 2018
- Published by Wiley in Anz Journal of Surgery
- Vol. 88 (9) , 860-864
Mobility scores as a predictor of length of stay in general surgery: a prospective cohort study
Background: Post‐operative length of stay (LOS) is an increasingly important clinical indicator in general surgery. Despite this, no tool has been validated to predict LOS or readiness for discharge in general surgical patients. The de Morton Mobility Index (DEMMI) is a functional mobility assessment tool that has been validated in rehabilitation patient populations. In this prospective cohort study, we aimed to identify if trends in DEMMI scores were associated with discharge within 1 week and overall LOS in general surgical patients.Methods: A total of 161 patients who underwent elective gastrointestinal resections were included. DEMMI scores were performed preoperatively, on days 1, 2, 3 and 30 post‐operative. Statistical analysis was performed to identify any association between DEMMI scores and discharge within 1 week and LOS.Results: Functional recovery (measured by achieving 80% of baseline DEMMI score by post‐operative day 1) was significantly associated with discharge within 1 week. Presence of a stoma was associated with longer LOS. The area under the receiver operating characteristic curve using functional recovery on post‐operative day 1 as a predictor of discharge within 1 week is 0.772.Conclusion: The DEMMI score is a fast, easy and useful tool to, on post‐operative day 1, predict discharge within 1 week. The utility of this is to act as an anticipatory trigger for more proactive and efficient discharge planning in the early post‐operative period, and there is potential to use the DEMMI as a comparator in clinical trials to assess functional recovery.
- 22 May 2018
- Published by Wiley in Anz Journal of Surgery
- Vol. 88 (9) , 860-864
Mobility scores as a predictor of length of stay in general surgery: a prospective cohort study
Background: Post‐operative length of stay (LOS) is an increasingly important clinical indicator in general surgery. Despite this, no tool has been validated to predict LOS or readiness for discharge in general surgical patients. The de Morton Mobility Index (DEMMI) is a functional mobility assessment tool that has been validated in rehabilitation patient populations. In this prospective cohort study, we aimed to identify if trends in DEMMI scores were associated with discharge within 1 week and overall LOS in general surgical patients.Methods: A total of 161 patients who underwent elective gastrointestinal resections were included. DEMMI scores were performed preoperatively, on days 1, 2, 3 and 30 post‐operative. Statistical analysis was performed to identify any association between DEMMI scores and discharge within 1 week and LOS.Results: Functional recovery (measured by achieving 80% of baseline DEMMI score by post‐operative day 1) was significantly associated with discharge within 1 week. Presence of a stoma was associated with longer LOS. The area under the receiver operating characteristic curve using functional recovery on post‐operative day 1 as a predictor of discharge within 1 week is 0.772.Conclusion: The DEMMI score is a fast, easy and useful tool to, on post‐operative day 1, predict discharge within 1 week. The utility of this is to act as an anticipatory trigger for more proactive and efficient discharge planning in the early post‐operative period, and there is potential to use the DEMMI as a comparator in clinical trials to assess functional recovery.
- 1 January 2018
- Published by Wiley in Anz Journal of Surgery
- Vol. 88 (1-2) , 117-118
Response to Re: How to do it: use of the Alexis wound protector as a laparostomy device
- 1 January 2018
- Published by Wiley in Anz Journal of Surgery
- Vol. 88 (1-2) , 117-118
Response to Re: How to do it: use of the Alexis wound protector as a laparostomy device
- 5 July 2017
- Published by Wiley in Anz Journal of Surgery
- Vol. 87 (9) , 732-733
How to do it: use of the Alexis wound protector as a laparostomy device
- 5 July 2017
- Published by Wiley in Anz Journal of Surgery
- Vol. 87 (9) , 732-733
How to do it: use of the Alexis wound protector as a laparostomy device